Non-Vitamin K Oral Anticoagulants Associated Bleeding and Its Antidotes
Thorsten Steiner, Martin Köhrmann, Peter D. Schellinger, Georgios Tsivgoulis
J Stroke. 2018;20(3):292-301.   Published online 2018 Sep 30     DOI: https://doi.org/10.5853/jos.2018.02250
Citations to this article as recorded by Crossref logo
Safety of direct oral anticoagulants in patients with atrial fibrillation and high risk of stroke (review of literature)
E. I. Baranova, V. A. Ionin, A. A. Katsap, O. S. Kolesnik, E. V. Lebedeva
The Scientific Notes of the Pavlov University.2020; 26(3): 43.     CrossRef
Risk factors associated with intracranial bleeding and neurosurgery in patients with mild traumatic brain injury who are receiving direct oral anticoagulants
Gianni Turcato, Arian Zaboli, Massimo Zannoni, Giorgio Ricci, Elisabetta Zorzi, Laura Ciccariello, Andrea Tenci, Norbert Pfeifer, Antonio Maccagnani, Antonio Bonora
The American Journal of Emergency Medicine.2020;[Epub]     CrossRef
Reversal Treatment in Oral Anticoagulant-Related Intracerebral Hemorrhage—An Observational Study Based on the Swedish Stroke Register
Trine Apostolaki-Hansson, Teresa Ullberg, Mats Pihlsgård, Bo Norrving, Jesper Petersson
Frontiers in Neurology.2020;[Epub]     CrossRef
Andexanet alfa for the reversal of factor Xa inhibitors
J Favresse, M Hardy, MA van Dievoet, AL Sennesael, J Douxfils, CM Samama, O Vornicu, AS Dincq, S Lessire, F Mullier
Expert Opinion on Biological Therapy.2019; 19(5): 387.     CrossRef
Patients on NOACs in the Emergency Room
Stefan T. Gerner, Hagen B. Huttner
Current Neurology and Neuroscience Reports.2019;[Epub]     CrossRef
Reversal of oral anticoagulation in patients with acute intracerebral hemorrhage
Joji B. Kuramatsu, Jochen A. Sembill, Hagen B. Huttner
Critical Care.2019;[Epub]     CrossRef
Cerebral small vessel disease: classification, clinical manifestations, diagnosis, and features of treatment
A. A. Kulesh, V. E. Drobakha, V. V. Shestakov
Neurology, Neuropsychiatry, Psychosomatics.2019; 11(3S): 4.     CrossRef